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Summary. This article documents understandings and responses to mass drug
administration (MDA) for the treatment and prevention of lymphatic filariasis
among adults and children in northern coastal Tanzania from 2004 to 2011.
Assessment of village-level distribution registers, combined with self-reported
drug uptake surveys of adults, participant observation and interviews, revealed
that at study sites in Pangani and Muheza districts the uptake of drugs was
persistently low. The majority of people living at these highly endemic locations
either did not receive or actively rejected free treatment. A combination of social,
economic and political reasons explain the low uptake of drugs. These include
a fear of treatment (attributable, in part, to a lack of trust in international aid
and a questioning of the motives behind the distribution); divergence between
biomedical and local understandings of lymphatic filariasis; and limited and
ineffective communication about the rationale for mass treatment. Other con-
tributory factors are the reliance upon volunteers for distribution within villages
and, in some locations, strained relationships between different groups of people
within villages as well as between local leaders and government officials. The
article also highlights a disjuncture between self-reported uptake of drugs by
adults at a village level and the higher uptake of drugs recorded in official re-
ports. The latter informs claims that elimination will be a possibility by 2020.
This gives voice to a broader problem: there is considerable pressure for those
implementing MDA to report positive results. The very real challenges of making
MDA work are pushed to one side – adding to a rhetoric of success at the
expense of engaging with local realities. It is vital to address the kind of issues
raised in this article if current attempts to eliminate lymphatic filariasis in main-
land coastal Tanzania are to achieve their goal.
Introduction
Current endeavours to eliminate lymphatic filariasis have been hailed as ‘a best buy in
global health’ (Ottesen, 2008, e317) and ‘the most effective pro-poor public health pro-
gramme’ (Molyneux, 2003, p. 1). They are part of an international agenda to ‘rescue
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the bottom billion through the control of neglected tropical diseases’ (Hotez et al.,
2009, p. 1570) with a view to helping ‘make poverty history’ (Molyneux et al., 2005,
p. 106). While there may be a degree of fundraising rhetoric in such statements, there
is no doubt that lymphatic filariasis presents a major public health problem for large
numbers of impoverished people. Recent estimates suggest that around 120 million
people living in tropical and sub-tropical environments are affected, with approximately
40 million displaying clinical signs of infection such as hydrocele (swollen scrotum),
lymphoedema/elephantiasis and a further 80 million people experiencing sub-clinical
signs of infection (Taylor et al., 2010).
Strategies to eliminate lymphatic filariasis currently rely heavily on the mass distri-
bution of drugs, free of charge, to all adults and children aged five or more living in
endemic areas. The drugs being distributed are albendazole, in combination with either
diethylcarbamazine citrate (DEC) or ivermectin; and recent reports suggest that more
than 570 million individuals, residing in 51 countries where lymphatic filariasis is
endemic, have received these drugs (Taylor et al., 2010). There are several reasons for
promoting mass drug administration (MDA).
First, it is important to break the cycle of transmission between mosquitoes and
human beings. Anopheles, Culex, Aedes and Mansonia mosquitoes are all capable of
transmitting parasitic worms (Wuchereria Bancrofti in Africa) that cause the disease,
lymphatic filariasis, in humans. The mass distribution of drugs provides an opportunity
to interrupt transmission, because the tablets have the effect of reducing the circulation
of microfilariae (the larvae of the parasitic worms circulating in the blood of infected
individuals). This, in turn, helps to prevent onward transmission.
Second, elimination of the disease is thought to be achievable with the drugs
mentioned above if a large enough proportion of the population swallow the tablets
being distributed. The necessary rates of drug take-up have been variously estimated
at 65–80% over four to six years (Mohammed et al., 2006) and 70–90% over six or
more years (Michael et al., 2004). In areas where the prevalence of microfilariae
is greater than 10%, Michael et al. (2004) have suggested that coverage levels of
90% or more may be necessary. Whatever the requisite coverage levels, multiple rounds
of treatment are essential because the drugs currently being used do not kill the adult
worms. Instead, they reduce the circulation of microfilariae until the worms naturally
die off, and it can take six years for this to occur (Michael et al., 2004; Bockarie &
Deb, 2010).
Additional reasons for promoting MDA include the fact that two pharmaceutical
companies, GlakoSmithKline and Merck, have agreed to donate the relevant drugs
until lymphatic filariasis has been eliminated from the globe (WHO, 2012). The drugs,
it is argued, can usually be distributed through existing national health mechanisms to
volunteers in the targeted communities. They are also considered to be safe enough
to be used without testing for infection, making it ethical, as well as cheap, to treat
everyone. In sum, it is argued that MDA for lymphatic filariasis is an ‘easy-to-do’ and
inexpensive health intervention (Molyneux, 2003, p. 13), a view that underpins the
World Health Organization’s Global Programme to Eliminate Lymphatic Filariasis.
By 2008, the results were reported to be ‘staggering’ and elimination of the disease
was anticipated to be a real possibility by 2020 (‘End in sight’ for elephantiasis, BBC,
8th October 2008, http://news.bbc.co.uk/1/hi/health/7659222.stm). Continuing optimism
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is reflected in statements such as those by the WHO Department of Control of Neglected
Tropical Diseases in 2011, suggesting the campaign is ‘halfway towards eliminating
lymphatic filariasis’ (http://www.who.int/neglected_diseases/integrated_media/integrated_
media_urogenital_lf_2011/en/index.html), and by those associated with the January 2012
joint London Declaration on Neglected Tropical Diseases (NTDs), in which partners
pledged new levels of collaboration and announced a co-ordinated push to accelerate
progress toward the eradication of lymphatic filariasis and the control or elimination
of a range of other NTDs (http://www.dfid.gov.uk/Documents/publications1/NTD%
20Event%20-%20Table%20of%20Commitments.pdf ).
The Tanzanian National Lymphatic Filariasis Elimination Programme (TNLFEP)
is part of these global operations to eliminate the disease. The TNLFEP began in 2000
and has expanded, year on year. In 2009, it was reported that it had covered 34 dis-
tricts in six regions, with 9.2 million people having been treated over a period of eight
years (Malecela et al., 2009a). Efforts to eliminate lymphatic filariasis from Tanzania
are also part of the national programme to control neglected tropical diseases (United
Republic of Tanzania, 2009). This programme was established in 2009 with a view to
co-ordinating efforts to control or eradicate a variety of tropical diseases including
schistosomiasis, soil-transmitted helminths, onchocerciasis, trachoma and lymphatic
filariasis. It is recognized in reports and official statements that an integrated and holistic
approach to lymphatic filariasis (and other neglected tropical diseases) is the ideal, and
that MDA should be combined with other methods. However, it would be fair to say
that, in practice, the focus has primarily been on the distribution of donated drugs.
Thus, the TNLFEP is meant to have other components. In addition to the mass distri-
bution of ivermectin and albendazole, it is intended that there should be vector control
(involving the use of bed nets and the reduction of breeding sites for mosquitoes); lym-
phoedema management; and hydrocelectomies (involving surgery for scrotal swelling
caused by the parasitic worm, Wuchereria bancrofti). Although the emphasis given to
these latter components may be different in other locations, such as Zanzibar (Mohammed
et al., 2006) and Mafia (Malecela et al., 2009a), at locations studied in this paper, vector
control was receiving almost no attention, and lymphoedema management was very
limited.
Previous research on lymphatic filariasis in mainland coastal Tanzania
A variety of epidemiological and health policy research has been undertaken on lymphatic
filariasis in coastal Tanzania (see, for example, Kolstrup et al., 1981; Meyrowitsch et al.,
1995, 2004; Nielsen et al., 2006; Rwegoshora et al., 2007; Simonsen et al., 2005, 2010;
Malecela et al., 2009b). Much of this research documents the prevalence of microfilariae
as well as visible signs of infection such as swollen scrotums, legs and feet. Simonsen
et al. (2010), for example, reported that in Kirare, a sentinel surveillance site located
about 20 km from the regional capital of Tanga, the overall prevalence of microfilariae
among individuals over the age of one was 24.5%, and it was 53.3% for Wuchereria
bancrofti-specific circulating antigen. They also noted that 4.1% adults aged 20 years
or more had elephantiasis of the leg and 32.8% adult men had hydrocele. These data
were collected in September 2004, immediately before the TNLFEP began the first
round of treatment. They indicate that, if the estimates of Michael et al. (2004) are
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correct, a daunting annual MDA take-up rate of at least 90% would be required to
interrupt disease transmission.
Simonsen et al. go on to document the effect of three rounds of mass treatment with
ivermectin and albendazole to adults and children aged five or more living in Kirare.
The reported findings suggest the uptake of drugs was less than the target rate, and
that uptake declined over time. Self-reported uptake fell from 82% in October 2004 to
79% in February 2006 and 69.9% in May 2007. Beneficial biological effects for the
population were nevertheless observed. Human infection with microfilariae declined,
and this led to a reduction in transmission. However, the effects thereafter levelled off
and transmission still occurred after the third round of MDA, albeit at a lower level.
Concerns were raised about the length of time between rounds of treatment (as they
were longer than the recommended period of one year) as well as the fact that mass
treatment had limited influence on adult worm burden. The article concludes by high-
lighting the ‘waning effect’ of MDA and the need for careful monitoring and evaluation.
This includes the need to make more accurate assessments of the number of people
receiving and actually swallowing tablets. With respect to the latter point, the authors
query the high rates of drug uptake recorded in official reports. This, in turn, raises the
additional issue of whether or not the uptake of drugs in Kirare represents the norm, or
whether proximity to Tanga town (the location of the regional referral hospital and
medical headquarters) combined with the regular visits of Tanga-based researchers,
facilitated higher than average treatment coverage for the region. It is likely that this
is the case as it would have been extremely difficult to have collected blood samples
without a significant proportion of participants understanding the purpose of the
research and the rationale for mass treatment.
Anthropologists are well-placed to assist with endeavours to assess the social and
biological consequences of mass treatment for the control of neglected tropical diseases
(NTDs) such as lymphatic filariasis. To the authors’ knowledge, they have not, as yet,
explored local responses to mass treatment programmes seeking to eliminate lymphatic
filariasis. This article attempts to reverse this trend. Building on research undertaken
in north-western, northern and south-eastern Uganda on two other neglected tropical
diseases, schistosomiasis and soil-transmitted helminths (Parker et al., 2008, 2012;
Parker & Allen, 2011), it addresses the following questions: is current enthusiasm for
the elimination of lymphatic filariasis on the global stage shared by those on the receiv-
ing end of these programmes? Is it appropriate to assume that adults will be willing, if
not grateful, to swallow tablets if they are provided free of charge, in the interests of
maintaining or preserving their own health? How does the social context in which
mass distribution occurs influence the uptake of drugs?
Field sites and methods
The article is based on research undertaken in northern coastal Tanzania from July to
September 2007 and July to August 2011. In 2007, ten weeks of fieldwork were under-
taken in the adjoining villages of Mwembeni and Jaira in Pangani district, the small
town of Kigombe in Muheza district and several other villages close to the town in
this district. Follow-up research occurred four years later over a period of five weeks.
Field research was led by the two authors. They were assisted by a group of four
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locally recruited researchers in 2007 and five locally recruited researchers in 2011, all of
whom were either secondary-school leavers or graduates who had been unable to find
employment.
Research in Mwembeni and Jaira villages in 2007 involved participant observa-
tion in a wide range of settings, including visits to homesteads, attending local healing
ceremonies, talking to villagers cultivating maize and cassava, and visiting local dis-
pensaries and the district hospital. In addition, 30 open-ended, unstructured interviews
were undertaken with local healers, health care providers and village elders; and village
meetings were held at various points during fieldwork to discuss the rationale for
the research and to feed back provisional findings. To complement this work, a 20%
random sample of households was generated from the 2004 Ministry of Health registers
documenting the uptake of drugs for lymphatic filariasis. Semi-structured interviews
were then undertaken with one adult from each selected household. Seventy-three
semi-structured interviews were undertaken with adults in Mwembeni village and 35
semi-structured interviews were undertaken with adults in Jaira village.
In July–August 2011, a further 118 semi-structured interviews were undertaken
with randomly selected adults in Mwembeni. In contrast to 2007, it was not possible
to use the Ministry of Health registers as a way of systematically identifying house-
holds in Mwembeni as the records were no longer based on census data detailing the
names of all residents living in the villages. Instead, the registers were simply a list of
names of people who had received treatment. A sample of households was thus derived
by visiting every other household in each of the sub-divisions of the village. In addi-
tion, participant observation and fifteen open-ended, unstructured interviews were
undertaken as well as an open meeting in the village to discuss key issues emerging
from the research.
In Muheza district, research was undertaken in Kigombe town and its environs.
For administrative purposes the area is divided into Kigombe East (and its sub-
villages) and Kigombe West (and its sub-villages). The peri-urban area of Kigombe
East runs along the edge of the sea. In addition, there are numerous villages, spread
out over many kilometres, located to the north-east along the coast road running
towards Tanga town. The peri-urban area of Kigombe West spreads inland from the
coast road and includes more distant rural villages such as Mchangani and Ndonde.
With the exception of the peri-urban area of Kigombe West (for which there was
a household list produced by an American anthropologist, Suzi Krehbiel, who had
lived in the area in 2006), local registers were unavailable or incomplete. It was thus
necessary to derive a sample of households by visiting every second home with a view
to interviewing a similar proportion of people to that achieved in Mwembeni and Jaira.
A total of 146 semi-structured interviews were undertaken in Kigombe West (including
the sub-villages of Mchangani and Ndonde) and Kigombe East (including the sub-
villages of Sinawe, Gawani and the village of Kitongoji) in 2007 and 144 semi-
structured interviews in 2011. The methods employed were the same as those described
for Mwembeni and Jaira in Pangani district, including a similar number of unstruc-
tured interviews.
Research was also undertaken in 2007 in two villages located close to the district
capital, Muheza town: Magila and Bwembwera. Here, 30 households were randomly
selected in Magila and 51 households were randomly selected in Bwembwera. Accord-
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ing to the lists of households kept by the village chairmen, this represented more than
20% of the estimated number of households. Semi-structured interviews were then
undertaken with one adult from each selected household.
All semi-structured interviews undertaken in Pangani and Muheza districts elicited
information about whether or not the adult being interviewed accepted free drugs for
the treatment and prevention of lymphatic filariasis. Information and ideas emerging
from participant observation fieldwork and open-ended, unstructured interviews were
subsequently used to interpret these quantitative data. Swahili is the dominant local
language in this part of Tanzania, as well as being the national language. Migrants
into the region all spoke Swahili, even when they also spoke their own languages
(such as Makonde). The vast majority of semi-structured and unstructured interviews,
as well as village meetings, were thus undertaken in Swahili.
Finally, an endeavour was made to elicit the perspectives of village-based drug dis-
tributors and district officials involved in the mass drug administration programme for
the control of lymphatic filariasis. Official records monitoring the uptake of drugs
by staff from the Ministry of Health were looked at wherever possible, and these were
discussed with the relevant staff in English.
Mwembeni and Jaira villages, Pangani district
Mwembeni village is about 8 km from Pangani town and lies on the main road that
links Muheza town to the coast. It is one of three villages that form part of Madanga
ward, and one of eight villages that form part of Madanga division. According to
census data published in 2006, 1126 people live in Mwembeni. The village is divided
into four sub-divisions: Mzia, Mwembeni, Makuyuni and Nunda. It is socially diverse,
with Christians (Protestant and Catholic) and Muslims (Sunni and Shia) living side-by-
side. The Christians are predominantly Makonde, and the Muslims are predominantly
Zigua and Zaramo. There is inter-marriage between these groups, although tensions
exist between Muslim groups (focused in particular on rival imams) as well as between
Muslim and Christian groups. It is not unusual for Muslims to talk about the
Makonde as migrants or ‘refugees’ from Mozambique, in spite of the fact that they
have lived in the village for two and even three generations. Many of their homes are
located at some distance from the village centres, in some cases in remote places.
Mwembeni village has one primary school and one small madrasa (Islamic school).
It also has several mosques and churches (both of the most basic variety). A small
number of people have access to piped water from a tap every other day, and there
are ten households with access to electricity, two of whom have a satellite dish. Broadly
similar characteristics apply to Jaira village, which lies a few kilometres north of
Mwembeni. According to Ministry of Health data collected in 2004, an estimated 539
people live in this village.
The majority of adults in Jaira and Mwembeni own or rent plots of land that
they cultivate. Others are employed on a temporary basis as farm labourers. A diverse
array of crops are grown including cassava, maize and rice. Coconut, orange, mango
and banana trees are grown too, though most people do not have access to all these
types of fruit trees. A small number of people fish for prawns in the river, and these
are mainly sold in Pangani town. It is important to note that very few people have
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regular, salaried work. Historically, the large-scale production of sisal at nearby estates
was an important source of regular employment, and explains the presence of so many
Makonde. However, decline in the global demand for sisal has led to a decline in
production and the laying off of staff. As part of the surveys on drug uptake discussed
below, adults living in Mwembeni and Jaira were asked what they considered to be
the most serious problems facing them: 58% mentioned unemployment and 26%
mentioned inadequate health facilities.
Kigombe and surrounding villages, Muheza district
Kigombe is a small town that lies on the coastal road linking the town of Tanga to
the town of Pangani. Although it is geographically much closer to Pangani, it is actually
part of Muheza district. It takes around two hours to drive to the district capital. Access
to the sea provides fishing opportunities to those with access to nets and boats, but the
majority of people rely upon the cultivation of cassava, maize and rice to survive, just as
they do in Mwembeni. Fifty-three per cent of surveyed adults highlighted unemploy-
ment as the most serious problem they faced compared with 31% who mentioned in-
adequate health facilities. There are several schools in Kigombe, including a madrasa,
and there are also several mosques and a government dispensary. The population is
mostly Muslim, but in common with Mwembeni, there is a Christian minority, generally
living a little further inland at the edges of the sisal fields. Also like Mwembeni, there
are divisions among the Muslims, but of a more intense nature. ‘Radical’ Islam has a
presence (with some openly sympathetic to Al Qaida in 2007). There are also divisions
between more orthodox Sunni Muslims and Muslims who are members of the Sudanese
Ansar sect. In contrast to Mwembeni, Kigombe is characterized by the amplified call to
prayer from rival mosques at night time. Other divisions relate to political activism,
with the local chairman being a member of Civic United Front (CUF), a political party
opposing the government.
Local ideas about illness and misfortune
Before addressing the specific issue of drug uptake for the treatment and prevention
of lymphatic filariasis, it is helpful to note that the study populations were found to
draw upon a broad range of ideas to understand illness and misfortune. Interpersonal
and spiritual aspects of well-being are often used to interrogate biomedical understand-
ings, with many kinds of illness being discussed in relation to the Swahili word uchawi.
The term uchawi may be translated as ‘witchcraft’, but it does not necessarily have the
same connotations as the English word. The majority of people interviewed in depth
talked about uchawi as being a constant threat, and many were surprisingly open about
the specific individuals who they suspected were most likely to use it. Even in the semi-
structured interviews, which were inevitably less probing, large numbers of people
stated that uchawi presented a problem. Those thought to be responsible are mostly
local healers or Christian migrants.
Notions about interpersonal and spiritual causes of affliction are also connected
with beliefs about and experiences of spirit possession. Those local healers with high
status were all found to be members of Swahili possession cults. In common with Giles
Mass drug administration and lymphatic filariasis 523
(1987, 1999), it became apparent that, unlike most possession cults in other parts of
Africa, these cults are closely connected with local hierarchies, and are expensive to
join. Possession is viewed as something dangerous and frightening, but paradoxically,
also carries high status and the possession cults operate as a parallel means of inter-
preting the spirit world to that of Islam. Indeed some of the practices observed were
strikingly un-Islamic (such as the ritual drinking of sheep blood). To the authors’
knowledge, no Christians were directly involved in these cults. It is also important to
note that considerable emphasis was placed on the training of healers at public se´ances.
For example, more than a dozen healers were present at a ritual that went on for
several days at one of the villages of Kigombe and half a day was allocated to discus-
sions between healers attending the ritual and those who had become new members of
the cult and would in the future be acting themselves as healers. Emphasis was placed
on the appropriate relationships they should have with their patients, implicitly con-
trasting them with the kinds of treatment expected at clinics. Their treatments involved
a combination of local remedies, concocted from locally available substances, with
spiritual and moral interpretations of affliction. The findings of respected healers
carried weight, and were not necessarily complementary with biomedical interpreta-
tions and treatments, including those for lymphatic filariasis.
Uptake of drugs for the treatment and prevention of lymphatic filariasis in Pangani and
Muheza districts, Tanga region
Uptake of drugs at villages in Pangani and Muheza districts, 2004–2007
By July 2007, three rounds of treatment had been distributed, free of charge, over a
four-year period for lymphatic filariasis. These took place in 2004, 2006 and 2007. In
both districts, registers were distributed by staff from the Ministry of Health to village-
based drug distributors prior to the first round of treatment in 2004. This enabled a
detailed record to be made of the names and ages of people living in each household
with a view to keeping a year-on-year record of the proportion of adults and children
receiving drugs for the treatment and prevention of lymphatic filariasis.
In Mwembeni village, distributors were found to have kept meticulous records of
the number of adults and children aged five and above who took the drugs for lym-
phatic filariasis. According to these registers, 59% of adults and children eligible for
treatment received the drugs in 2004; whereas 46% of them received treatment in 2006
and 34% received treatment in 2007. In short, the registers suggested there had been a
decline in the uptake of drugs. Data derived by selecting a 20% random sample of
households and then interviewing one adult from each selected household also indi-
cated a decline. That is, 71% of adults interviewed in Mwembeni said that they received
treatment in 2004; whereas 49% received treatment in 2006 and 35% received treatment
in 2007. These data are presented in Table 1.
The table also shows that very similar findings were recorded in neighbouring Jaira
village. The Jaira registers suggested that 55% received treatment in 2004; 43% received
treatment in 2006 and 42% received treatment in 2007. In common with Mwembeni, a
20% random sample of households was taken from the 2004 Ministry of Health drug
distribution registers. One adult was interviewed from each selected household, and
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data emerging from these interviews also conveyed a decline in the uptake of drugs.
That is, 56% adults received treatment in 2004, 50% received treatment in 2006 and
38% received treatment in 2007.
Ministry of Health registers documenting the uptake of drugs in Kigombe and
surrounding villages could not be located. However, data collected in the course of
undertaking semi-structured interviews suggested a downward trend. Table 2 shows
that 47% of those interviewed in Kigombe said they received treatment in 2004, 45%
received treatment in 2006 and 22% received treatment in 2007. A different picture
emerged in the northern part of Muheza district. In the village of Bwembwera, inter-
views indicated that 47% received treatment in 2004, 69% received treatment in 2006
and 65% received treatment in 2007; whereas in Magila, 40% received treatment in
2004, 43% received treatment in 2006 and 70% received treatment in 2007.
Uptake of drugs among adults in Pangani and Muheza districts, 2008–2010
In July–August 2011, 118 semi-structured interviews were undertaken with a random
sample of adults in Mwembeni, Pangani district, to assess the proportion of adults that
had received ivermectin and albendazole for the treatment and prevention of lymphatic
filariasis since 2007. As indicated in Table 3, the self-reported uptake of drugs was
below 50% for the period 2008 to 2010. A brief follow-up survey was also carried out
in Jaira village. Taking a sample of randomly selected households near the trading
centre, seventeen adults were interviewed, with 70% of them stating they had received
the tablets. Follow-up research was also undertaken in Kigombe town and surrounding
villages during this time. One hundred and forty-four semi-structured interviews were
undertaken and Table 3 shows that the self-reported uptake of drugs remained below
50% from 2008 to 2010.
Table 1. Uptake of drugs for the treatment and prevention of lymphatic filariasis
among adults in Pangani district, Tanga region, 2004–2007
2004 2006 2007
Drug uptake among adults and children in village registers
Mwembeni villagea 202 (59%) 402 (46%) 306 (34%)
Jaira villageb 263 (55%) 164 (43%) 160 (42%)
Self-reported drug uptake among interviewed adults
Mwembeni village, N ¼ 75 53 (71%) 37 (49%) 26 (35%)
Jaira village, N ¼ 34 19 (56%) 17 (50%) 13 (38%)
a In Mwembeni village, the total number of people listed in the drug distributors’ registers that
were eligible for treatment was 345 in 2004, 869 in 2006 and 901 in 2007. The fact that fewer
people appeared to be eligible for treatment in 2004 can almost certainly be attributed to the
fact that some of the registers had been lost.
b In Jaira village, the total number of people listed in the drug distributors’ registers that were
eligible for treatment was 475 in 2004, 386 in 2006 and 386 in 2007. The fact that fewer people
appeared to be eligible for treatment in 2006 and 2007, compared with 2004, is probably attribut-
able to the fact that some of the registers had been lost.
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Official district statistics on the uptake of drugs in Pangani and Muheza districts,
2004–2010
Official statistics submitted to the Ministry of Health from Pangani district differ
from the information recorded in the Ministry of Health village drug distribution
registers. That is, the overall uptake of drugs for lymphatic filariasis among adults
and children more than five years old was reported to be 67.6% in 2004, 78% in 2006,
76.5% in 2007 and 75.2% in 2010. Aware of the possibility that these aggregate figures
may reflect much higher levels of drug uptake in other parts of the district, a decision
was made in 2007 to go through all the available official village-based, drug distribu-
tion registers for Pangani district in order to double-check the accuracy of the official
figures. In addition to the registers for Mwembeni and Jaira, registers were found for
six of the 33 villages that constitute Pangani district. These villages were: Barabani,
Chakaloboko, Mahakamani, Boza, Kimanga and Msaraza Bushiri. Not all registers
for these villages were found to be complete for all three recorded rounds of drug
distribution, but according to the registers available, drug uptake fell short of the
sustained high coverage levels that are required to eliminate lymphatic filariasis. To
be more specific, the uptake of drugs among the 4755 adults and children listed in the
available registers as eligible for treatment in 2004 ranged from 49% in one village to
93% in another village, and the average uptake for all eight villages was 65%. How-
ever, the uptake of drugs declined in all villages except one in 2006. That is, uptake
ranged from 81% to 35%, and the average uptake among the 7823 adults and children
listed as being eligible for treatment was 46%. In 2007, there were further declines
in the majority of villages. Uptake ranged from 81% in one village to 7% in another
village and the average uptake was 34% among the 6436 adults and children listed as
being eligible for treatment.
Table 2. Self-reported drug uptake for the treatment and prevention of lymphatic
filariasis among adults in Muheza district, Tanga region, 2004–2007
Village 2004 2006 2007
Kigombea, N ¼ 146 68 (47%) 66 (45%) 32 (22%)
Bwembwera, N ¼ 51 24 (47%) 35 (69%) 33 (65%)
Magila, N ¼ 30 12 (40%) 13 (43%) 21 (70%)
aKigombe includes Kigombe East and Kigombe West. Kigombe East includes the sub-villages
of Sinawe, Gawani and Jitingeni and Kigombe West includes the sub-villages of Ndone and
Mchangani.
Table 3. Self-reported drug uptake for the treatment and prevention of lymphatic
filariasis among adults in Mwembeni, Pangani district, and Kigombe, Muheza district,
2008–2010
Village 2008 2009 2010
Mwembeni, N ¼ 118 26 (22%) 45 (38%) 56 (48%)
Kigombe, N ¼ 144 45 (31%) 57 (40%) 49 (34%)
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The average figure for 2004 was thus very similar to that in the officially submitted
report, but the high drug uptake reported in 2006 and 2007 in the official records
submitted to the Ministry of Health did not correspond with the drug uptake data
recorded in the village registers. While it is possible that the uptake of drugs is higher
in other parts of Pangani district, this is an unlikely scenario. Many of the villages for
whom drug distribution registers could not be found were located south of Pangani
town. This part of the district is often inaccessible to district staff as it involves crossing
the Pangani River by a ferry that is prone to mechanical breakdowns. Technical diffi-
culties aside, budgetary constraints at district headquarters restrict the frequency with
which staff can visit villages and facilitate the distribution of drugs – not least because
many of the villages are located a considerable distance south of the river. As a result,
difficulties go unnoticed and tend to increase, rather than decrease, over time. (These
difficulties are discussed further on in this article.)
It was much harder to elicit comparable data about the uptake of drugs in Muheza
district. In 2007 and 2011, considerable efforts were made to talk to district officials in
Muheza as well as associated officials at a ward, village and sub-village level, but no
Ministry of Health registers could be located in 2007, and only a small number could
be located in 2011. In addition, it was difficult to make much sense of the information
presented in the registers that could be located as they only provided a list of the names
of people that had received treatment in 2010. In other words, in common with the
registers located in Mwembeni in 2011, it was not possible to use the information to
assess the proportion of people in any one village that had received treatment.
Nevertheless, summary statistics compiled at a district level (and subsequently pre-
sented as part of a regional report submitted to the Ministry of Health in Dar es
Salaam in 2009), recorded an uptake of drugs in the district of 81% in 2006, 76% in
2007 and 81% in 2008. The neglected tropical diseases co-ordinator for Muheza district
also reported coverage of 83% in 2009 and 83% in 2010 – whilst acknowledging that
the uptake of drugs was less in Kigombe as official returns suggested an uptake of
69% in 2009 and 65% in 2010 (personal communication, August 2011). While these
figures are lower than the 100% uptake reported to the research team by a district
official in Muheza in July 2007, they are still much higher than those recorded in the
course of interviewing randomly selected adults at selected villages in Muheza district.
Assessing the accuracy of data recording the uptake of drugs
Discrepancies between the figures derived from semi-structured interviews, the official
district figures, and the figures in the village-based registers raise important questions
about the relative merits of the methods employed to elicit information on drug uptake.
With respect to data arising from semi-structured interviews, is it really possible for large
numbers of adults to accurately remember whether or not they have received a particular
combination of drugs over an extended period of time? Is it possible that some informants
muddle up the years that they received them and the years that they did not? Is it appro-
priate to assume that informants receiving drugs during MDA actually swallowed them?
Whatever is done to alleviate anxieties and ensure that those being interviewed recount
events as accurately as possible, is it possible for informants to try and second-guess
the ‘correct’ answer to be polite or to just make the researchers leave them alone?
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Identical questions emerged whilst undertaking research on social responses to
MDA for the treatment of schistosomiasis and soil-transmitted helminths in northern
and south-eastern Uganda (Parker et al., 2008, 2012; Parker & Allen, 2011). Here it
was found that those interviewed clearly recalled treatment, partly because praziquantel
tablets, which are used to treat schistosomiasis, are unusually large, pungent and un-
palatable. In addition, the free distribution of biomedical drugs to treat adults is a rarity
and not something easily forgotten. Indeed, it is widely commented on and the issue is
less whether or not people remember, and more whether or not they are willing to say
what happened to the drugs once they had received them. In some cases it became clear
that instead of swallowing them immediately, they had kept all or some of their dose for
future use if they felt ill, or to give to relatives and friends.
The situation was found to be slightly different with respect to MDA for lymphatic
filariasis in coastal Tanzania, not least because the drug, ivermectin, is small, easy to
swallow and does not have an unpleasant smell. Albendazole is equally straightforward
to consume. Nevertheless, few people struggled to recall whether or not they had received
free treatment – partly because it was so unusual to offer free medicines to adults and
partly because it was considered to be very strange indeed to ask all adults to swallow
medication, irrespective of whether or not they felt ill. In fact, the vast majority of
people interviewed were remarkably forthcoming about their reasons for accepting
or rejecting treatment and, more often than not, they asked pertinent questions about
the rationale for the control programme that shed further light on why, for example,
some people accepted treatment in the early years of the programme and subsequently
declined treatment; while others declined treatment but subsequently accepted treat-
ment for one or two years, before deciding to reject treatment again.
In general, data recording the uptake of drugs from semi-structured interviews
undertaken at randomly selected households are, in most cases, likely to more accurately
convey the proportion of adults that received the tablets than the data embedded in the
official Ministry of Health registers by village-based drug distributors. There are several
reasons for this. First, villages can be quite dispersed and drug distributors were some-
times found to be unaware of all people living in the village. Second, social divisions
within a village can often affect the kind of people recorded. In Mwembeni, for example,
the long-standing differences between Muslims and Christians were found to have influ-
enced the number of people registered. Some of the resident Christian Makonde were
dismissed as ‘refugees’, or even ‘not real people’. Third, short-cuts are often taken in
the time-consuming job of handing out tablets. Close discussion with the distributors
and people receiving drugs revealed that the protocol of observing consumption was
often not followed. In several instances, it was found to have been largely set aside, in
a similar manner to the practice noted above with respect to praziquantel distribution in
Uganda. As a result, it is not known if those who are recorded as having taken the
drugs have actually swallowed them. Thus, drug uptake data in the village-based distri-
bution registers may overestimate, rather than underestimate, actual consumption.
This is not to suggest that the data in the Ministry of Health registers are always
inaccurate. On the contrary, some drug distributors went to great lengths to carefully
record the names, ages and sex of the people they gave drugs to. However, the
consistency of registration between distributors was found to vary; and it was often
impossible to judge the quality of the recorded data without checking them. In most
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cases, they provided, at best, a partial picture of the proportion of people in a specific
geographical area that had received treatment.
A more worrying issue is that the summary statistics compiled at a district level on
drug uptake suggest much higher levels of drug uptake than data eliciting drug uptake
among adults in the course of interviews. While the latter data only refer to adults, it is
likely that they provide a useful proxy of the extent to which MDA programmes reach
adults and children at the selected study sites. The reasons are straightforward: mass
treatment occurs through village drug distributors, rather than school teachers; and if
adults are willing to receive (and possibly consume) tablets for themselves, then they
are almost always willing to receive tablets for their children. Similarly, if they reject
medication for themselves, then they are likely to reject treatment for their children.
It is also worth noting that in those instances in 2004 and 2005 when village drug
distributors recorded the numbers of people living in a village on a household-by-
household basis in the Ministry of Health registers and whether or not each person
had received drugs, there was a similar discrepancy – with drug uptake being much
lower in the registers than the aggregate figures recorded at a district level. Senior
district officials, when asked to comment on the discrepancies, were quick to set aside
the higher figures. One of them disarmingly observed: ‘people are just sitting down and
cooking the numbers’. He went on to express frustration with the treatment pro-
gramme by saying ‘this programme has no legs’. This was a literal reference to the
shortage of fuel and other resources enabling staff to spend the requisite time in villages
explaining the rationale for mass treatment. He was, in short, not surprised by the
lower drug uptake figures emerging from field-based research. This view was shared
by others working at district headquarters. In short, there is no doubt that the uptake
of drugs is low at the selected study sites (and rates of take-up in other highly endemic
coastal villages in Pangani and Muheze districts are likely to be similar). Why is this
the case?
Why is the uptake of drugs for the treatment and prevention of lymphatic filariasis low?
The low uptake of drugs cannot be attributed to a lack of awareness of the signs and
symptoms of lymphatic filariasis. While there is no Swahili word for the disease, two
of the major clinically recognized signs of infection, swollen scrotums and swollen
limbs, are perceived locally as separate afflictions, with the former being referred to as
mabusha and the latter as matende. Both are feared, even if they are not considered as
life-threatening as malaria or HIV/AIDS. Adults participating in the surveys on drug
uptake were asked what they thought were the major illnesses affecting local people.
Malaria was cited by far the most frequently. It was mentioned by 64% of those inter-
viewed at study sites in Pangani and 78% of those interviewed at study sites in Muheza,
whereas HIV/AIDS was mentioned by 29% of adults in Pangani district and 19% of
adults in Muheza district. Mabusha was mentioned by 27% and 24% in Pangani and
Muheza districts respectively and matende by 12% and 15% – although ‘muscle or leg
pain’ was also mentioned by 26% and 20% of adults respectively in these two districts.
In more open-ended discussions, mabusha, in particular, was spoken about as a
constant threat for men. Typically, statements were made about it generating feelings
of shame and misery. For example, a 27-year-old man from Jaira village explained that
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mabusha is a torturing disease: ‘[it] makes you sad, unhappy, everyday’ (all such quotes
in the article have been translated from Swahili). Another man, aged 31, and also from
Jaira said, ‘I feel so ashamed, especially with those I respect. . . . I have access to women
but they always say: ‘‘I don’t want you, because you will give me the infection’’.’ Others,
including a 52-year-old man from Kigombe, complained that ‘people talk about you
when you are not there. It makes you fearful and anxious . . . No woman will want
you if you have mabusha . . . unless they are a witch and they want your money. . .’.
In some cases, the distress, misery and desperation was so intense that men tried to
operate on themselves. In 2007, for example, a 40-year-old man from Mwembeni told
us that he had operated on himself twice to try and drain the fluid from his scrotum.
Tragically, he died in 2008, reportedly whilst trying to perform the operation on
himself for a third time. Attitudes to matende tended to be more stoical, but the worst
cases observed were shocking, with afflicted individuals, mostly women, being hidden
away out of site.
Given that mabusha and matende are widely recognized to cause sickness and suf-
fering, one might assume that the provision of free treatment would be welcomed.
Why, then, are the majority of adults not taking the drugs? Are they being distributed
appropriately? If so, does it follow that adults are actively rejecting treatment? The rest
of this section demonstrates that there is no single explanation for the low uptake
of drugs. Rather, a combination of social, economic and political reasons explain
the low uptake of drugs at the different study sites. These include: fear of treatment
(attributable, in part, to a lack of trust in international aid and a questioning of the
motives behind the distribution); divergence between biomedical and local understand-
ings of lymphatic filariasis; insufficient and inadequate communication about the
rationale for mass treatment; and too great a reliance upon too few volunteers to dis-
tribute drugs within villages. These issues are discussed in turn.
Fear of treatment
Mass drug administration for mabusha and matende generated anxiety and scepticism
among the majority of adults, with informants questioning the motives behind the free
distribution of drugs by the Tanzanian government and international agencies. A young
man from Jaira, for example, said: ‘There is something strange going on. If the govern-
ment want to help us, they should distribute malaria drugs for free, not matende and
mabusha.’ Similarly, a 40-year-old man from Mwembeni commented that, ‘there is no
sign [on the drug] that it is for mabusha or matende . . . you have to trust in the govern-
ment to swallow the tablets . . . trust matters a lot. If you don’t trust them, you can’t
swallow the drug . . . the programme doesn’t come with enough knowledge.’ Mean-
while, in Kigombe, a man in his 50s justified not taking the tablets in the following
way: ‘In this village we cry for water . . . they haven’t brought water for free, but they’ve
brought drugs for free. Why? These free drugs have to be for an experiment . . . that
is why I reject them.’ These kinds of comments were typical in locations with low drug
uptake and highlight the fact that the rationale for distributing tablets for mabusha
and matende, free of charge, was poorly understood. Acutely aware that clinic-based
biomedical practitioners tend to diagnose infections before administering drugs, and
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confused why such an approach was deemed unnecessary by the Tanzanian government
in this case, rumours circulated about the ‘real’ intentions behind the free distribution.
A very prevalent concern was the idea that the drugs had been designed to reduce
population growth. As one man in Kigombe put it: ‘they are lying about this drug. It is
not for mabusha or matende . . . [it is] a family controlling pill . . .’. Younger men discus-
sing this issue tended to emphasize the idea that the tablets reduced their sexual energy.
For example, at a village meeting in Mwembeni, a young man summarized the views
of others when he said, ‘They are afraid . . . they say if you are infected [and you] take
the drug then your penis will never erect again.’ It was a view echoed at a comparable
group discussion at Kigombe, where a man in his mid-30s proclaimed that ‘[People
from the] rich countries send us this drug to reduce our malehood energy and to make
us infertile, because the wazungu (white people) were fed up giving us help every day.’
For others, the focus was more on the way the tablets might be intended to prevent
conception, a view that was probably supported by the reluctance of some drug dis-
tributors to give the tablets to women who said they were pregnant. For example,
a man in his 60s living in Mwembeni commenting on local views said, ‘They say if
you take the drug, you will never give birth . . . they believe the government has failed
to convince them to enter into family planning.’ Women were particularly likely to say
something comparable. Thus, a young woman from Kigombe commented that, ‘These
drugs are coming from Europe. We know women in Europe have two children and their
intention is to make Africans like Europeans. They think we can’t manage so many
children, that we can’t provide proper education, health care and home environment.’
Concerns about infertility were also connected with the experiences of some of
those who had swallowed the drugs. There was considerable discussion about side-
effects. A man in his 30s from Mwembeni, for example, described how he took the
tablets in 2006 and experienced a strong fever with rashes. He went on to say that he
did not take the drug again as he feared the side-effects. Others expressed concern that
the drugs exacerbated existing symptoms, and even infected people with mabusha and
matende. A woman from Kigombe, for example, said that she did not take the drugs in
2004 as she was pregnant. She subsequently rejected treatment in 2006 and 2007 as she
had ‘. . . seen people infected by those drugs in 2004 . . . there were some who got body
pain and fever. If I took those drugs, I would be infected too . . .’. In a similar vein, an
elderly woman from Mwembeni said: ‘They were afraid that if they took the tablets the
busha would get bigger,’ and a man from Kigombe said: ‘They are afraid that if they
take the drug they will get matende or mabusha . . .’. There were, in addition, stories
that were even more alarming. A young man from Mwembeni, for example, said:
‘they fear the drugs will kill them . . .’. He was not the only one to mention this. He
went on to explain that, ‘most people do not receive reliable information and knowl-
edge about the drugs.’
These last remarks relate to prevalent doubts about drug efficacy. This is hardly
surprising as few, if any, people were aware that it was possible to be infected and
asymptomatic and almost all of those with mabusha and/or matende complained that
the drugs were not making much or any difference. For example, a man in his 60s
from Kigombe had lived with mabusha since his mid-40s and took the treatment in
2004, 2006 and 2007, but declined free treatment in subsequent distributions. He
explained that, ‘The drugs make no difference . . . the weight of my testicles disturbs
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me.’ His experience was shared by a younger man who had accepted treatment in 2004,
but subsequently refused it. He complained: ‘I have hernia and mabusha. When they
announced the treatment, they said it would cure me. I took it, but it didn’t work. So
why take it again? Some other people I know took the drug and then got mabusha, so
they didn’t take it again either.’ These perspectives were widely shared. A woman in her
30s with matende who had also taken the drugs only once summed up attitudes when
she said: ‘We are getting no relief from the medicine . . . the drugs are not working.’
Divergence between biomedical understandings of lymphatic filariasis and local
understandings of mabusha and matende
Widespread fears, anxieties and rumours emerge, in part, from villagers making
their own empirical observations about the side-effects associated with treatment and
the limited visible efficacy of the drugs. They also draw attention to the disjuncture
between biomedical understandings and responses to lymphatic filariasis and local
understandings and responses to mabusha and matende, which are perceived locally as
entirely separate afflictions. To quote a local healer (mganga) from Pangani: ‘Some
people have both mabusha and matende . . . but they don’t come simultaneously. The
fact that mabusha can be operated on and matende cannot be operated on, proves that
they are different diseases . . .’.
The majority of people do not attribute a single cause to either mabusha or
matende. Indeed, it is not unusual for three or four causes to be mentioned, and for
each to be accorded equal weight. This sub-section discusses local understandings and
responses to mabusha and matende. In so doing, it becomes apparent that these locally
recognized afflictions are understood in a context where virtually everyone, including
health care workers at government dispensaries and health centres, draws upon a
pluralistic approach to diagnosis and treatment to understand sickness and misfortune.
It is also worth noting that discussions about mabusha, and to a lesser extent
matende, can be infused with moral overtones, with spirit mediums sometimes threat-
ening those who are thought to be behaving badly by saying that they will ‘throw a
busha’. In Madanga division, for example, there was a ceremony associated with the
local possession cult called Mwaka Koga, part of which was held at a sacred well on
the outskirts of a village. People gathered spoke to the spirits in the well. At one point
in the ceremony, the spirit medium said: ‘Protect us, cure us and treat us so that we can
be healthy and have peace and happiness in our lives. . . . There are some . . . who see
those who come to us as barbaric, uncivilized and ignorant; and they see themselves as
educated, civilized and more religious . . . They only believe in one God . . . [To them
we say:] give them bushas and matende and never cure them, until they come here and
beg for forgiveness.’
Local understandings and responses to mabusha. The majority of adults are unaware
of any relationship between mosquitoes and mabusha. Of the 335 adults interviewed
whilst undertaking drug uptake surveys in Pangani and Muheza districts in 2007, just
11% attributed mabusha solely to the bites of mosquitoes. While a small proportion of
informants attributed mabusha to the bites of mosquitoes and other causes (notably
acts of witchcraft, sex, hernia, dimensions of diet, acts of God), the vast majority of
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informants either did not mention mosquitoes as a possible cause or remained uncon-
vinced about their role in transmission. On one occasion, during a village meeting, a
female sub-village leader took issue with the biomedical explanation being put forward
by a health worker about the aetiology of mabusha and said: ‘we can fight to the death,
but you will never get me to believe that it is not caused by sex with a menstruating
woman!’
The reference to sex is important here. It highlights the fact that mabusha is widely
talked about as a sexually transmitted disease. For example, a Christian man from
Mwembeni explained that, ‘The blood is full of vidudu (micro-organisms) . . . God
created menstruation to clean the woman from vidudu . . . but these vidudu get into
a man if they have sex when she is bleeding [and it leads to mabusha].’ A Muslim
elder added, ‘the vidudu in the blood passes into the penis and it can lead to mabusha.’
Others agreed with this point, but emphasized that it was only possible to get mabusha
from a menstruating woman if the sex occurred outside of marriage. Thus, a woman
from Mwembeni said, ‘If you steal someone’s wife, who is protected by the healer,
then you get mabusha with vidonda (severe rashes on the penis),’ and a man from
Kigombe said, ‘if you have sex with a prostitute that is menstruating, you can get
mabusha . . . you see, they will never tell you that they are menstruating as they want
the money.’
In addition to sexual intercourse, other explanations for mabusha include one or
more of the following: a lack of food, eating too many coconuts and/or drinking
immature coconut juice, being bitten by mosquitoes and acts of God. Hernia, too, is
closely associated with the occurrence of mabusha. A 62-year-old male, for example,
commented: ‘A hernia is a disease. Inside the hernia, there are intestines which fall
down towards the testicles. Oil or water from inside the intestines pass down into the
testicles and make a busha.’ Similarly, a local mganga said: ‘it catches you at the waist . . .
the muscles around the waist can squeeze the hernia, and the fluid goes into the
testicles,’ and a young man, speaking at a village meeting, said: ‘if you have a hernia,
your testicles swell . . . but it doesn’t mean that it’s hydrocele [although] most people
think that it’s not possible to have a hernia and not have busha . . .’.
Ideas about witchcraft also play a central role in local understandings of the aetiology
of mabusha. Here, it is helpful to note that different kinds of mabusha are recognized
locally, with some kinds being more overtly linked to acts of witchcraft than other
kinds. Two of the most widely recognized kinds of mabusha are: busha la maji and
busha la mafuta. Busha la maji is thought to be effectively treated by surgery at hospital
as the water can be drained away, whereas busha la mafuta is not thought to be
treatable in a hospital setting. As one 70-year-old male said: ‘. . . even if the fatty oil is
scraped out, it just fills up again . . .’. Others spoke of busha la mkoba and busha la
uchawi. With respect to busha la mkoba, it is interesting to note that the word mkoba is
Swahili for woman’s handbag and that witches are sometimes thought to carry the tools
of their craft in their testicles. As one mganga said: ‘mgangas who hide their tools in a
mkoba are not mgangas. They are witches, but they exist.’ Busha la uchawi translates as
‘bewitching busha’ and a local mganga described it in this way: ‘. . . in the village, if you
have a conflict with a man in the village, he will bewitch you . . . there are some diseases
that cannot be cured by biomedicine, only by herbs. Diseases like busha la uchawi
cannot be treated at the hospital . . .’.
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Many local mgangas and other villagers talked about their ability to make mabusha.
A 35-year-old woman from Kigombe, for example, said: ‘If you have a quarrel with a
person, they can take revenge and punish you by making mabusha . . . there is nothing
you can do . . . no drugs can help.’ It is important to note, however, that several
mgangas did not concur with the view that mgangas were capable of ‘throwing a
busha’. As one mganga from Madanga pointed out: ‘Mgangas sometimes say they can
‘throw a busha’, but this is not the work of a mganga. It is the work of a mchawi (witch/
sorcerer). The work of mgangas is to cure, not to make sickness.’
Whatever the role of mgangas, it became apparent that the majority of informants
linked the occurrence of some kinds of mabusha to acts of witchcraft, with the type
of mabusha influencing the type of treatment sought. Moreover, mgangas are usually
consulted to determine the cause of mabusha, and if it is deemed to be busha la mafuta,
then biomedical treatment is avoided. Busha la maji is thought to be treated by doctors
and most mgangas recommend biomedical treatment, as they do not think they can
treat anything but the early signs of mabusha such as fever. It is important to note,
however, that some informants did not differentiate between types of mabusha. Instead,
they advocated biomedical treatment in all cases. For example, a 63-year-old Christian
Makonde in Mwembeni remarked that: ‘It is a shameful disease and you can’t live with
it . . . you must be operated on as quickly as possible . . . No local mganga operates on
mabusha.’ Similarly, a Muslim man from Kigombe observed that, ‘The best [thing to
do] is to go to hospital for an operation . . . it is difficult for a mganga to treat mabusha
because he has no equipment and no knowledge of what to do.’
In general, it was found that there is considerable demand for surgical treatment.
However, many men do not go down this route as it normally costs approximately
100,000 Tanzanian Shillings (about £40.00) and few have the necessary income to pay
for it. An exception is when the operations have occasionally been offered free. In
2007, for example, names of individuals who stated that they had hydroceles and
wanted an operation but could not pay for it were collected at the field sites. Their
names were then passed on to district health staff. The TNLFEP was additionally
alerted to the very large number of cases. Two hundred operations were subsequently
carried out on some of these men as well as other individuals at a surgical camp in
Pangani district with special funding in 2008 (Malecela, 2009a, p. 55; personal com-
munication by email on October 19th 2007). Partly as a consequence, scores of others
needing operations made themselves known to the research team in 2011 (roughly 1:10
men in Mwembeni), although many stated that, even if the operations are free, they
would find it hard to be treated, because they could not afford not to work for six
months after the operation. To quote a 30-year-old man from Mwembeni: ‘[They tell
us] you can’t do masculine (i.e. heavy) jobs for six months, but how will our children
eat then? What we do to earn a life is tough work . . . if you rest for six months, your
children will die.’
Others are afraid to be operated on. One man, reflecting on the fact that his friend
showed no inclination to get treatment from the hospital, said: ‘he has decided to tie a
tight rope around his testicles to try and prevent them from swelling.’ Others are afraid
that they will die if they are operated on. This fear relates to anxiety as to whether
they have busha la maji or busha la mafuta as the latter needs to be treated by a mganga
and, more significantly, treatment at a hospital is not only inappropriate, but can
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lead to death. To quote a mganga from Mwembeni: ‘Some mabusha is caused by
uchawi . . . if you go to a hospital for an operation and it is caused by uchawi, you will
die immediately.’
Local understandings and responses to matende. In common with mabusha, villagers
attributed matende to a number of different causes. It was not unusual for several
explanations to exist side-by-side and for each one to be deemed of equal importance.
Matende, for example, was often said to be an inherited condition as well as being
caused by mgonzo fever and/or the bite of a mosquito. In contrast to mabusha, the
majority of adults at all study sites said that they did not know what caused matende,
but mgonzo fever was widely recognized as an early sign of matende. It is very different
to the fevers associated with malaria, and one male informant described it in the
following way: ‘Mgonzo is a fever, a very strong fever. When it catches you, you will
be seriously ill, to the extent that you urinate unconsciously, shiver and speak non-
sense. When the fever comes down, the leg starts to swell. Two or three days later, the
swelling goes down and the skin peels off. He or she might be OK for a year [but] then
they will experience the fever again, until it becomes tende . . . It is best treated with a
painkiller.’ Similarly, a Muslim woman from Kigombe East said: ‘Homa mgonzo can
lead to matende. [It] is very strong . . . you feel very, very cold and shiver all over . . .
the fever goes into the body’s muscles and the effect of this is that it goes into the legs
and feet and leads to swelling. Some people can get swellings in their arms too.’
Various causes are attributed to the occurrence of mgonzo, including open wounds
and sexual intercourse. The logic is clear: ‘I cut my foot while I was farming and, soon
afterwards, I got mgonzo. It was not [an ordinary] homa (fever) as the head does not
hurt if you have homa and my head was hurting. . . . Some people also get matende
from mosquitoes, but I didn’t,’ (Muslim woman from Kigombe who has had matende
for many years); ‘Mgonzo is a strong fever that leads to a swelling of the legs. I get this
fever once a year and so does my wife. Now her leg is starting to swell . . . I think I gave
it to her through sexual intercourse,’ (Christian Makonde man from Mwembeni).
In contrast to mabusha, a sizeable number of informants mentioned mosquitoes as
the sole cause of matende (for example, 37% in Kigombe West in 2007). Explanations
for how mosquitoes transmit matende included the following: ‘I heard that mosquitoes
cause matende and I think it is true . . . maybe the mosquito has poison inside it and
this is why the legs swell,’ (a man in his 50s from Kigombe East); ‘There is a mosquito
called Culex . . . when that mosquito bites someone with matende and then bites you,
you will get matende,’ (a man in his 80s from Kigombe West).
Inter-personal and metaphysical explanations also featured in peoples’ narratives.
As noted, this applies more to mabusha than matende. Nevertheless, like any other
affliction, such interpretations were a possible explanation, often in combination with
others. Here are a few examples: ‘My mother gave birth to 12 children. People were
jealous of her and they made uchawi (witchcraft) to give her matende,’ (60-year-old
man from Mwembeni); ‘When you have a conflict with someone, that person will go
to a local mganga and make matende by using spiritual force,’ (34-year-old woman from
Kigombe); ‘Mchango . . . it is in your stomach, it eats the food you take in. It is like a
worm. There are good mchangi and bad mchangi. Bad mchango causes minyoo, busha
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and matende, together with safura (hookworm),’ (65-year-old man from Kigombe); ‘I got
matende by stepping over uchawi (witchcraft),’ (56-year-old woman from Mwembeni).
Others emphasized the fact that matende was an inherited condition. Here are state-
ments made at a group discussion: ‘I think it is caused by a mosquito, but many people
think it is inherited.’ ‘If your father has it, then it can be passed on to sons, daughters,
grandchildren . . . like having twins.’ ‘If the parent has twins, then anyone in the family
can have them.’ ‘My wife has matende in her right leg and her mother suffers from it
too. She inherited the condition.’
Although it is less common with respect to matende to assert a witchcraft explana-
tion, the view is sometimes expressed that it is possible to differentiate between the type
of matende caused by a mosquito and the type of matende caused by witchcraft. The
following quotes are a good examples of the range of perspectives frequently exchanged
among groups of people sitting together with an afflicted person and commenting on the
problem: ‘There is no treatment for ‘normal matende’, but witch matende can be treated
by mgangas (local healers).’ ‘Women can stop matende by wearing several pairs of
underwear to stop it spreading.’ ‘Inside the matende is oil . . . if you go to the hospital,
they can remove the oil and the swelling will come down.’ ‘The normal matende can be
cured, and the swelling goes down, after treatment at the hospital. The other kind does
not go down with hospital treatment.’
Limited and ineffective communication
It has been argued that social mobilization and advocacy is a key component of
effective MDA for lymphatic filariasis in Tanzania (Malecela et al., 2008, p. 117). This
is said to comprise everything from radio spots to posters, film shows and the use of
mobile megaphones. All this activity is reported to occur in Swahili and to have been
incorporated into a set of lymphatic filariasis control ‘programme principles’. While
these activities may well have occurred at some locations, it is also the case that they
either have not occurred or they have had a minimal effect at the field sites where this
research occurred. As a result, very few people understood the rationale for distributing
drugs, free of charge, to adults and children. Staff employed at health centres, as well as
village-based drug distributors, were thus genuinely confused as to whether the drugs
were designed to prevent infection or treat existing infections. With few exceptions,
they had no idea that it was possible to be infected and asymptomatic and they were at
a loss about how to answer frequently posed questions. These included variations of the
following, all of which were posed at village meetings and/or during interviews in 2007
and 2011:
Why should I take the tablets when I feel well? Why do the tablets need to be taken by
everyone once a year? How can one drug protect someone from two different afflictions?
Why should I take the tablets again as I took the tablets last year and I still feel ill? Why
should I take the drugs as I do not have mabusha or matende? I took the drugs last year
as I have mabusha, but the swelling did not go down. Why should I take them again?
How can these drugs prevent mabusha when it is caused by witches and spirits? Why is
there an operation for mabusha, but not matende? Why do some people get fevers and
others swollen bodies after swallowing the tablets? Why do drug distributors allocate
the number of tablets according to height rather than weight? Why are Europeans manufac-
turing tablets for mabusha and matende when they do not suffer from these diseases?
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At all sites there was an eagerness to engage in debate and discussion about these
issues, and innumerable complaints that the drugs were being given out by local dis-
tributors who could not explain how they worked or exactly what they were for. As
one young woman from Kigombe put it: ‘there is no information about why you
should take the drugs, what the drugs are for and other necessary information to
convince people to take the drugs.’ With so many unanswered questions, it is hardly
surprising that people questioned the merits of mass treatment.
What appears to be an unwillingness or an incapacity to engage with local concerns
of these kinds, and specifically to address matters such as pluralistic approaches to
aetiology and treatment in health education materials and training of distributors,
is by no means unique to staff working for the National Programme to Control
Neglected Tropical Diseases in Tanzania (see, for example, research on the control of
schistosomiasis and soil-transmitted helminths in Uganda by Parker et al. (2008) and
Parker & Allen (2011), and research on malaria by Hausmann Muela et al. in Tanzania
(1998, 2002)). It does, however, have unfortunate consequences as it ends up confirm-
ing, rather than refuting, existing outlooks and fuels anxieties about the merits of
swallowing drugs provided by international donors and distributed through government
channels. That said, it would be a great mistake to assume that more extensive and
sophisticated communication will be sufficient to improve drug uptake. The current
system of rolling out free drugs relies upon voluntary labour to run the programme
and this, too, is problematic. The next section discusses this issue.
Too great a reliance on voluntary drug distributors
Village health workers, otherwise known as the ‘community’s own resource persons’
(CORPS) take responsibility for distributing drugs for the treatment of mabusha and
matende (Malecela et al., 2009b). They are trained through a cascade system. That is,
health workers at a national level train health workers at a regional level; regional staff
train staff working at a district level; and district staff train those working at a ward and
village level (Malecela et al., 2008). Village drug distributors are not paid for the time
they spend handing out drugs within their villages, but they receive a small ‘sitting
allowance’ for attending training sessions. While positive statements have been made
about the effectiveness and efficiency of the cascade system (Malecela et al., 2008,
2009b), observations and discussions with health workers and other villagers suggest
that the current system does not always run smoothly.
In particular, it overlooks the fact that some villages cover significant geographical
areas and there are often significant constraints preventing distributors from taking the
time to contact those living on the outer reaches of their village. To walk from home to
home, persuading individuals with whom there is little social connection, requires a big
commitment. This is expected to occur in addition to a normal day’s work, and may
need to be done repeatedly, because many individuals may be absent, perhaps fishing
or farming or visiting relatives. Crucially, the reliance upon a small number of adults
to distribute drugs within each village also assumes that a sense of goodwill and con-
cern extends to all residents equally. In many places, this is not the case.
In Mwembeni, for example, the Makonde are, in social and political terms, much
more marginal than their Muslim neighbours. They are often referred to as kafir. As
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a result, many of them are not even recorded in the village register. In addition, it
became apparent that by 2010 a parallel system of drug distribution had emerged.
That is, two Muslims were taking responsibility for distributing drugs throughout the
village. Christian Makonde living reasonably close to the centre of the village were told
to come to a central location to collect drugs, but those living ‘far’ from the centre were
not informed of the treatment. A 55-year-old Makonde man, living on the outskirts of
the village, summed up the situation when he revealed that he had never heard about
the free provision of drugs as: ‘the only information we get is when we have to con-
tribute something . . . the other news is not delivered.’ By contrast, many of the friends,
neighbours and relatives of the drug distributors were being given drugs in their own
houses. Somewhat similar issues were also noted in Kigombe, where divisions between
political parties, between Muslim factions and between Muslims and Christians all
affected distribution activities. As in Mwembeni, many Christians complained that
they were not informed about the drug distributions. Moreover, in 2007, one of the
imams was reported to have openly opposed distribution activities to his followers,
and the distributors lacked the authority or knowledge to challenge him.
Such diverse (and often very locally specific) divisions in what are perceived externally
as homogeneous communities obviously affect drug distribution. Indeed, close scrutiny
of a programme like Tanzania’s National Lymphatic Filariasis Elimination Programme
makes manifest social hierarchies and fissures. They become particularly clear in ethno-
graphic research, though they may be hard to enumerate. Although efforts were made
to see if it was possible to discern consistent patterns of treatment exclusion in the data
that were collected during semi-structured interviews on drug uptake, this did not prove
particularly insightful. Political affiliation, for example, was too sensitive an issue to be
asked in all interviews, and it was sometimes difficult to assess the accuracy of answers
when they were forthcoming. Systematic effects of the manifest conflicts and tensions
in the Muslim population were similarly hard to gauge and quantify. However, with
respect to drug distributers’ coverage of resident Christians, it was possible to make
a basic assessment in Mwembeni. Here, there were some Christians living near the
primary school, not far from the village centre, or who had children at the school.
They tended to be offered tablets. It was those residing at the periphery of the village
that were omitted. Also, a general bias towards offering tablets to Muslims in preference
to Christians was discernible in the self-reported uptake data: between 2004 and 2007,
53% of Muslim adults reported taking the tablets in Mwembeni, and 48% of Christians.
Ethnographic research on this and other issues revealed that there were marked differ-
ences of attitude and commitment among drug distributors. Observations and discus-
sions strongly indicated that it was the most marginal that end up being excluded from
the offer of treatment.
Why is self-reported drug uptake higher at some locations?
It remains to be explained why self-reported drug uptake is higher in some places
than others. The answer is relatively straightforward. It relates to levels of engagement
with the target populations and resulting increased capacity of people to make informed
choices. It has already been observed that the proximity of the official sentinel site near
Tanga town at Kirare and the visits of medical staff and researchers explain a relatively
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high self-reported uptake rate, even if it is less than is necessary for long-term control or
elimination of the disease. Similar rates were noted in this study, in Bwembwera and
Magila in Muheza district and at the small trading centre of Jaira in Pangani district.
The case of Jaira was discussed with district medical staff based at the hospital in
Pangani town in 2011. The District Medical Officer commented that the improvement
in self-reported drug take-up (from a low of 40% in 2007 to around 70% in 2010) must
have been to do with the direct involvement of his staff. Some of his staff had been to
Jaira at the time of distribution and had responded personally to the questions and
concerns of the population. It was not possible to do so elsewhere due to lack of trans-
port and lack of qualified personnel who might be deployed.
With respect to Bwembwera and Magila, the take-up rates of 68% in 2006 and 65%
in 2007 in Bwembwera, and 70% in 2007 in Magila, probably reflect their proximity to
Muheza town and to Muheza hospital. It was found that in these locations knowledge
about lymphatic filariasis and the rationale for mass treatment had been more ade-
quately communicated than in locations near the coast. In addition, it was reported
by informants that surgery had been made available to those men seeking it through
an established system of referral, rather than the kind of ad hoc surgery camp that
was run in Pangani in 2008. District medical staff additionally noted that higher rates
of drug uptake near to Muheza town reflected the better training and larger number of
drug distributors than was the case in more remote locations. They were well aware
of the difference in levels of engagement within the district, and explained that they
just did not have the resources to run a more effective operation at a distance from
their base.
Conclusion
The research presented in this article is based upon fieldwork undertaken in northern
coastal Tanzania. It demonstrates that the uptake of drugs at selected study sites in
Pangani and Muheza districts falls short of the sustained high coverage levels required
to eliminate lymphatic filariasis, and the prospect of eliminating the disease by 2020
with current strategies is remote. In broad terms, the findings presented in this article
add to the worrying conclusions of Simonsen et al. (2010), who report that drug uptake
at the nearby and closely studied sentinel surveillance site at Kirare, while higher than
those reported at the study sites in this paper, is insufficient; and that MDA is having
declining effects on disease control. In combination with research undertaken by
Michael et al. (2004, 2008) and Gambhir et al. (2010), results presented here highlight
the pressing need to fine-tune mass treatment programmes according to ecological,
biological and social factors operating at a local level. The results also highlight the
need for more adequate monitoring, recognizing that there are risks involved in sustaining
MDA with partial coverage over time, including risks associated with drug resistance
(McCarthy, 2005).
Elsewhere in the country, findings have been more encouraging. Considerable success,
for example, has been reported in Zanzibar (Mohammed et al., 2006; Mohammed, 2008).
Here, the prevalence of microfilariae has fallen from 17.8% and 7.2% to less than 2% at
two sentinel surveillance sites, following five annual rounds of mass treatment. Where
there are apparent successes of this kind, it would be helpful to know exactly why they
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have occurred. The present trend in the NTD literature, driven by target-orientated
funding, is to assume they are inevitable. Explanations for the reported achievements
in Zanzibar include sustained high MDA coverage of 70–80% over a five-year period,
linked to the introduction of effective lymphoedema management programmes. It is
probably also significant that the prevalence of microfilariae was initially lower than
that recorded at Kirare. It is not clear, however, whether these lower levels were due to
other vector control activities that may have been running in the vicinity for lymphatic
filariasis and/or malaria or whether they reflect the relative affluence and ease with
which Zanzibari populations can access public health interventions and other forms of
biomedical care compared with populations in Tanga region on the mainland. What-
ever the explanation(s), it is dangerous to simply assume that the results can be readily
replicated. There are specific reasons why MDA works in some places and fails in
others; and it is crucially important to know what these reasons are.
The mixed effects of MDA for lymphatic filariasis have specific aspects but in other
ways are not unique. Mass distribution of drugs for other neglected tropical diseases
faces comparable problems. In Tanzania, Hastings documented the uptake of ivermectin
and albendazole for the treatment and prevention of onchocerciasis in Doma, Morogoro
region, in 2007. Working with a 20% sample involving 150 randomly selected adults,
her research suggested that uptake fell from 31% in 2004 to 29% in 2006 and 17%
in 2007 (Hastings, personal communication). Wingate-Saul documented the uptake of
the drug praziquantel for the treatment and prevention of infection with S. mansoni.
Working in fourteen villages in Ukerewe Island, her research suggested that in 2007
drug uptake among adults ranged from 18% to 74%, with the average uptake being
44% (Wingate-Saul, 2008). These rates are well below target levels, and it is not clear
what effect they are having on the prevalence of infection. Meanwhile, a disturbing
indicator of how local fears and rumours can spiral out of control are the violent riots
that occurred in several locations during 2008 in response to MDA for the treatment
and prevention of S. haematobium in schools. Hastings had to be rescued from her
research location near Morogoro by armed Tanzanian police. Some teachers found dis-
tributing drugs were not so lucky and were beaten by angry mobs convinced that tablet
distribution had sinister motives, such as population control (IRIN Humanitarian News
and Analysis, 2008; Daily News Online Edition, 2008).
There are, of course, well documented accounts of social resistance to other top-down
biomedical disease control programmes such as vaccination programmes to control polio
in Nigeria (Yahya, 2010; Renne, 2011) and tetanus in Cameroon (Feldman-Savelsberg
et al., 2000); as well as the provision of condoms to prevent the transmission of HIV/
AIDS in parts of Indonesia (Butt, 2005), Botswana (Heald, 2000) and South Africa
(Niehaus & Jonsson, 2005). With respect to neglected tropical diseases, there has also
been some active resistance to treatment in Uganda, if not on the scale of the Tanzanian
riots. These have been described in relation to MDA for schistosomiasis in north-west
Uganda (Parker et al., 2008, 2012; Parker & Allen, 2011).
How, then, should fears associated with the mass distribution of drugs for the treat-
ment and prevention of lymphatic filariasis be addressed? It may be tempting for policy-
makers and planners to feel that the most effective way to respond to the low uptake of
drugs for lymphatic filariasis is to continue to focus on narrow technical and logistical
aspects of drug delivery as there is little they can do to counter rumours that the govern-
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ment and international agencies have hidden agendas that do not serve the interests of
local people. This would be a mistake. However misplaced local fears and anxieties
about free treatment actually are, they are also ideas that are widely held and have
emerged from experiences and empirical observations. White (2000), reflecting on the
persistence of vampire stories in Africa, and Geissler & Pool (2006), analysing rumours
associated with medical research projects in sub-Saharan Africa, have demonstrated the
multiple ways in which stories and rumours articulate local understandings of the work-
ings of power and knowledge.
Given that it is politically and economically neglected people who are mostly infected
with neglected tropical diseases, it is hardly surprising that the targets of vertical MDA
projects do not necessarily take the stated intentions of those running them at face
value. Their concerns and questions need to be acknowledged and understood. There
is a need for a real engagement with such populations, necessitating different kinds of
local-level strategies. With respect to lymphatic filariasis, it is quixotic to imagine that
MDA will work in isolation. A range of interventions are required, and social em-
powerment needs to be part of the mix. New ways have to be found to explain the
rationale for mass drug administration; that mabusha and matende are signs of the
same infection; that it is possible to be asymptomatic and infected with parasitic worms;
that the drugs being provided will not necessarily reduce the swelling of those suffering
from matende or mabusha; that the purpose of combining the drugs invermectin and
albendazole is to prevent those who are infected but asymptomatic from developing
clinical signs of infection; and that the drug albendazole also has the capacity to treat
those suffering from other worms, notably soil-transmitted helminths. There has to be
knowledge transfer for afflicted people to be able to make informed choices. As Allotey
et al. (2010) note, the current emphasis on context-free, pathogen-focused NTD control
is a return to ‘magic bullet’ medicine, and ignores the fact that vaccines and drugs do
not cure neglect or poverty.
Perhaps the largest challenge of all is not how to win round the hearts and minds
of those being targeted for treatment, but rather how to create a space whereby those
engaged in developing policies at a global level feel able to acknowledge that the types
of difficulties discussed in this paper are significant and that raising them is helpful and
relevant for developing more effective strategies. Considerable institutional pressures
mitigate against effective action, not least because intense competition for funding
discourages critical thinking and analysis (Allen & Parker, 2011, 2012). There is a
tendency towards disingenuous dismissal of important information, both social and
biological, and an overemphasis on quickly achieving optimistic goals. It has led to
some questionable claims about what has already been achieved, and to some strongly
worded responses to the kind of research presented here.
A global commitment to control or eliminate lymphatic filariasis and other neglected
tropical diseases is a hugely positive development, but that is all the more reason to avoid
treating fundraising rhetoric as facts, and to learn lessons from what has happened with
such large-scale vertical schemes in the past. As a 2010 editorial in The Lancet observed:
‘Evaluation must now become the top priority in global health. Currently, it is only an
afterthought . . . Without proper monitoring and accountability, countries and donors –
and taxpayers – have no idea whether or how their investments are working,’ (The Lancet
2010, p. 526.) With respect to MDA, there is a need for sober and rigorous assessment,
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which examines locally specific effects and subjects reported results to appropriate critical
scrutiny. Even if claims about ‘making poverty history’ and ‘alleviating the suffering of
the bottom billion’ are set aside as overblown, it is certainly possible that programmes
have potential to assist some poor and marginal populations. However, without heeding
warnings and amending strategies, that window of opportunity may be lost.
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